LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Stratasys Still Waiting for Critical Due Diligence and Regulatory Analysis From 3D Systems MINNEAPOLIS &…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA is pleased to announce the assignment of preliminary ratings to 38 classes…
RESTON, Va.–(BUSINESS WIRE)–AIS (Applied Information Sciences), experts in helping organizations modernize and innovate with Microsoft…
Vancouver, British Columbia–(Newsfile Corp. – July 28, 2023) – NetCents Technology Inc. (CSE: NC) (FSE:…
Toronto, Ontario–(Newsfile Corp. – July 28, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that analyzes nonperforming loan (NPL) transactions issued following the global…
Company recognized as a Best Place to Work for Disability Inclusion RADNOR, Pa.–(BUSINESS WIRE)–Lincoln Financial…
New collaboration reflects companies’ shared commitment to addressing customers’ data complexity and infrastructure modernization challenges…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…